Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study

CEYHAN, MEHMET; KARADAĞ ÖNCEL, EDA; Badur, Selim; Ciblak, Meral; Alhan, Emre; Celik, Umit; Kurugol, Zafer; SAZ, EYLEM; ÖZSÜREKCİ, YASEMİN; ÇELİK, MELDA; Parlakay, Aslinur

doi:10.1016/j.ijid.2011.12.008

Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study

Atıf İçin Kopyala

CEYHAN M., KARADAĞ ÖNCEL E., Badur S., Ciblak M. A., Alhan E., Celik U. S., ...Daha Fazla

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.16, sa.4, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 4
Basım Tarihi: 2012
Doi Numarası: 10.1016/j.ijid.2011.12.008
Dergi Adı: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Influenza, Children, Symptom duration, Oseltamivir, CHILDREN, BURDEN, HOSPITALIZATION, INFECTION, COMPLICATIONS, EPIDEMIOLOGY, OUTCOMES, THERAPY, ILLNESS, DISEASE
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: The aim of this multicenter prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B, and H1N1 during the 2010-2011 influenza season.